Bharat Biotech to attend a pre-submission meeting with WHO with regard to 'emergency use listing'

Bharat Biotech is set to attend a pre-submission meeting with WHO with regard to 'emergency use listing'. WHO, on June 18 accepted its Expression of Interest (EoI) for Covaxin and scheduled a pre-submission meeting for today. Bharat Biotech is the manufacturer of India's homegrown vaccine against COVID Covaxin which will have an opportunity to submit a summary on the overall quality of the shot to the WHO. TIMES NOW's Sherine brings in more details to this report. Watch the full video to know more about this story and stay updated with the latest news and breaking stories only on Times Now.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting